UBS Group Has Lowered Expectations for Agilent Technologies (NYSE:A) Stock Price

Agilent Technologies (NYSE:A) had its price target reduced by UBS Group from $180.00 to $165.00 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. UBS Group’s price objective suggests a potential upside of 36.27% from the company’s previous close.

A number of other analysts also recently weighed in on A. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price target for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Robert W. Baird raised their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. The Goldman Sachs Group initiated coverage on shares of Agilent Technologies in a research note on Tuesday, December 9th. They set a “buy” rating and a $170.00 price target on the stock. TD Cowen cut their price target on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday. Finally, Citigroup raised their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. Two analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $161.29.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $121.08 on Thursday. Agilent Technologies has a 12 month low of $96.43 and a 12 month high of $160.27. The stock has a market capitalization of $34.25 billion, a PE ratio of 26.73, a price-to-earnings-growth ratio of 3.51 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The business has a 50 day simple moving average of $134.67 and a 200-day simple moving average of $135.91.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.95% and a net margin of 18.26%.The firm had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same period in the prior year, the company earned $1.31 earnings per share. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities analysts predict that Agilent Technologies will post 5.58 earnings per share for the current year.

Hedge Funds Weigh In On Agilent Technologies

Several hedge funds have recently added to or reduced their stakes in A. Capital A Wealth Management LLC lifted its holdings in shares of Agilent Technologies by 10,600.0% in the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 212 shares in the last quarter. Core Wealth Advisors LLC purchased a new position in Agilent Technologies during the fourth quarter worth $26,000. Board of the Pension Protection Fund acquired a new position in shares of Agilent Technologies in the fourth quarter worth $27,000. Navalign LLC acquired a new position in shares of Agilent Technologies in the fourth quarter worth $27,000. Finally, Davis Capital Management purchased a new stake in shares of Agilent Technologies in the third quarter valued at $28,000.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Management raised FY‑2026 revenue ambition to $7.3B–$7.5B and highlighted expansion of its Ignite operating system as a path to future margin improvement. Read More.
• Positive Sentiment: Most sell‑side firms remain constructive (buy/overweight) and retain multi‑quarter price targets well above the current level despite trimming targets this week — supporting medium‑term upside if growth/margins recover. Read More.
• Neutral Sentiment: Agilent issued Q2 FY2026 EPS guidance of $1.39–1.42 and FY EPS of $5.90–6.04, which sits roughly around Street expectations — guidance is not a major beat or miss. Read More.
• Neutral Sentiment: Q4/CY2025 results were reported in line with expectations earlier, so the current reaction is focused on Q1 specifics and forward execution rather than a broader trend break. Read More.
• Negative Sentiment: Q1 results narrowly missed: EPS $1.36 vs. $1.37 consensus and revenue ~$1.80B vs. ~$1.81–1.84B estimates — the miss (and a weak margin cadence) triggered a near‑term selloff in earnings reaction. Read More.
• Negative Sentiment: Management said a severe U.S. winter storm disrupted shipments and service in the quarter, pressuring near‑term revenue and gross margins — investors may see this as a risk to near‑term execution. Read More.
• Negative Sentiment: Operating profit and operating cash flow declined year‑over‑year (cash from operations down notably), which raises short‑term concerns about margin leverage and free‑cash‑flow conversion. Institutional trimming noted in recent filings adds to near‑term selling pressure. Read More.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.